Amendment #145 to H5699
Preservation of Accountable Care Model A
Mr. Arciero of Westford moves to amend the bill by adding the following:
SECTION XX. (a) Notwithstanding any general or special law to the contrary, the executive office of health and human services, acting through the office of Medicaid, shall not implement any material change to the MassHealth accountable care organization program that would eliminate, materially reduce, or discourage provider participation in the Accountable Care Partnership Plan model, commonly referred to as Model A, or preferentially encourage participation in the Primary Care Accountable Care Organization model, commonly referred to as Model B, until:
(i) the Centers for Medicare and Medicaid Services has approved the Commonwealth’s section 1115 demonstration waiver extension for the demonstration period beginning January 1, 2028; and
(ii) the executive office has complied with the requirements of this section and has submitted the evaluation required by this section to the clerks of the house of representatives and senate, the joint committee on health care financing and the house and senate committees on ways and means.
(b) Changes subject to this section include contractual, participation, payment, incentive, risk-sharing or operational requirements that materially disadvantage Model A, restrict provider participation or managed care contracting under that model, impair its financial or operational viability, or encourage providers to transition to another delivery model. These restrictions apply regardless of whether a change is implemented through procurement, contract renewal or amendment, administrative guidance or other means.
(c) Before submitting its evaluation, the executive office shall meaningfully consult with Medicaid managed care organizations, participating accountable care organizations, affected providers and representatives of MassHealth members; disclose the supporting data, assumptions and methodologies; and provide a reasonable opportunity for written comment.
The evaluation shall assess:
1. Effects on provider participation, contracting, reimbursement, financial risk and administrative obligations; member access, provider networks and continuity of coverage and care; and care management, coordination and integration.
2. Functions currently performed or financed by managed care organizations, including clinical, administrative, financial and regulatory functions, and the costs of assuming, duplicating, replacing or separately financing those functions under the proposed changes.
3. Comparative performance in quality, utilization, total cost of care and financial accountability, and whether the Commonwealth’s objectives could be achieved through improvements to Model A without eliminating or materially reducing participation.
4. The independently verifiable net financial impact on the Commonwealth and MassHealth, accounting for all transition and ongoing costs, replacement functions, changes in medical spending and financial risk, lost economies of scale, cost shifting and additional funding needs.
The financial analysis shall separately identify gross savings, incremental expenditures, costs transferred to providers or other entities, and net savings, including state and federal shares. It shall disclose supporting data, assumptions, methodologies and sensitivity analyses and distinguish demonstrated savings, projected savings and transfers of financial responsibility. Eliminated or transferred payments, responsibilities or risks shall not constitute net savings unless all corresponding replacement costs and obligations are included.
(d) No change subject to this section shall take effect unless the evaluation demonstrates, using reasonable and transparent assumptions, that the change is expected to produce measurable net savings to the Commonwealth without materially diminishing member access, quality, care coordination or continuity of care.
(e) Nothing in this section shall prohibit changes necessary to comply with federal law or requirements, routine administrative improvements, strengthened quality or program integrity standards, or other reforms that do not materially disadvantage Model A or impair provider participation.